What drove the PATH stock drop today?

PATH stock fell after visible insider selling by the CEO and CFO, mixed analyst notes and profit-taking. Higher trading volume of **20,021,900.00** shares amplified the move while valuation and sentiment reacted to coverage changes.

How is PATH stock valued versus peers?

PATH stock trades at a trailing PE near **40.15**, price/sales **5.80**, and price/book **4.72**, which are above many software-infrastructure peers, reflecting expected growth but higher multiple risk.

What does Meyka AI forecast for PATH stock?

Meyka AI's forecast model projects a quarterly price of **$18.51** and a yearly price of **$15.03**. The quarterly target implies **15.48%** upside from **$16.03**. Forecasts are projections, not guarantees.

Should investors buy PATH stock after the drop?

Decisions depend on risk tolerance. PATH stock shows growth metrics and a B+ Meyka grade, but insider sales and high multiples increase short-term risk. Consider position sizing, support at **$15.19**, and upcoming earnings when deciding.

US Stocks

PATH stock $16.03 intraday (09 Jan 2026): 10% drop tests AI thesis

ByDanny Kontos January 9, 2026January 9, 2026

PATH stock fell to $16.03 intraday on 09 Jan 2026, a -10.15% move from the prior close on heavy volume. UiPath, Inc. (PATH) trades on the NYSE in the United States and is a core AI automation name that is reacting to mixed analyst notes and recent insider sales. We review the price action, key metrics—including PE 40.15 and market cap $9,017,363,898.00—and what this means for AI-focused portfolios.